| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03911514 |
| PharmacoGx | BRD-K03911514 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | ARFGAP3 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | LDLRAD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | PPP4R3A | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | BDP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | AC124312.1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | SMARCC2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | NWD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | RAB3IP | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
